Every Form 4 that Centene Corporation (CNC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CNC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNC filings page.
CENTENE CORP (CNC) reported that Corporate Controller & CAO Theodore J. Pienkos had 1,092 shares of common stock withheld on September 15, 2026 to pay tax liabilities upon vesting of a previously reported restricted stock unit grant. After this withholding, he holds 28,751.493 shares directly, including 13,763 restricted and performance stock units subject to vesting requirements. No Rule 10b5-1 trading plan is reported.
CENTENE CORP (CNC) insider Christopher Koster, Secretary & General Counsel, reported selling 56,500 shares of common stock on 2026-08-26 in an open-market or private transaction at a weighted average price between $66.90 and $66.91. After this sale, he directly holds 248,853.991 shares, including 229,874 restricted stock units and performance stock units reported at target performance and subject to vesting requirements. He also reports 100 shares of indirect ownership held by his spouse. The transactions were not affirmed as being under a Rule 10b5-1 trading plan.
CENTENE CORP (CNC) reported that officer Christopher Koster, Secretary & General Counsel, sold 47,603 shares of common stock on 2026-08-18 in an open-market transaction at a weighted average price of $65.36 per share, with individual sale prices ranging from $65.28 to $65.45. Following this sale, his reported direct ownership is 305,353.991 shares, which includes common stock acquired through the company’s Employee Stock Purchase Program and 229,874 shares of previously granted restricted stock units and performance stock units at target performance, all subject to vesting requirements. An additional 100 shares are reported as indirectly owned by his spouse.
Centene Corp director Paul J. Diaz reported an equity compensation award of 2,771 restricted stock units, recorded as a grant/award acquisition of common stock at a stated price of $0.0000 per share. According to the award terms, all 2,771 units will vest in full at Centene’s 2027 annual meeting of stockholders, after which the underlying shares become fully earned. Following this transaction, Diaz’s directly reported common stock holdings stand at 2,771 shares.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Centene Corporation director Lauren M. Tyler reported an equity compensation grant involving 3,155 shares of restricted stock units on 2026-07-17. According to the filing, these units will vest in full on the date of the company’s 2027 annual meeting of stockholders, bringing Tyler’s direct holdings to 3,216 shares.
Tyler Lauren M reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Lauren M. Tyler reported a small stock grant. On the reported date, Tyler received 61 shares of Centene common stock as a grant or award at no purchase price. Following this transaction, Tyler directly holds 61 Centene common shares.
Centene Corp director Kenneth Tanji received an equity grant of 581 shares of Common Stock as a compensation award. The shares were acquired at no cash cost to him, increasing his direct holdings to 12,490 shares. His ownership also includes 3,992 restricted stock units that are subject to vesting requirements.
Centene Corporation director Theodore R. Samuels II received a grant of 465 shares of common stock at no cost as a stock award. After this acquisition, he directly holds 25,212.979 common shares and indirectly holds 32,000 shares through a revocable family trust, which includes 3,992 restricted stock units that vest over time.
Centene Corp director Frederick H. Eppinger received a stock grant. On this date, he acquired 833 shares of Centene common stock at no stated purchase price as a grant or award. Following this award, his directly held position increased to 369,537.658 shares, including 6,654 restricted stock units that are subject to vesting requirements.
Centene director Christopher J. Coughlin reported updated equity holdings, including a new share award. He received a grant of 562 shares of Centene common stock at no cost, classified as a grant or award acquisition and held directly, bringing his direct holdings to 18,710.926 shares.
Coughlin also reports 30,054 shares of common stock held indirectly through a grantor retained annuity trust for the benefit of himself and his adult children, where he serves as sole trustee. Footnotes state his ownership includes 3,992 restricted stock units that are subject to vesting requirements.
Centene Corp Chief Operating Officer Susan Raye Smith reported a tax-related share disposition linked to equity compensation. On this Form 4, 483 shares of Centene common stock were withheld at $65.19 per share to cover taxes upon vesting of a previously reported restricted stock unit grant.
After this tax-withholding disposition, Smith directly owns 212,237 shares of Centene common stock. Her ownership also includes 181,082 shares tied to previously granted restricted stock units and performance stock units, which remain subject to vesting requirements.
Centene Corp director Kenneth A. Burdick reported an open-market sale of 80,000 shares of Centene common stock at $64.55 per share. A footnote explains that the weighted average sale price reflects trades between $64.55 and $64.61 per share, with detailed breakdowns available on request.
Following this sale, Burdick directly holds 197,085.924 Centene shares, which include 3,992 restricted stock units subject to vesting requirements. Separately, 86,498 Centene shares are held indirectly by the Burdick Family LLC, where he is a chief manager but disclaims beneficial ownership beyond his pecuniary interest.
Centene Group President Michael A. Carson reported a discretionary transaction involving phantom stock tied to Centene common shares. He reallocated 604.004 phantom stock units under the company’s nonqualified deferred compensation plan from an investment option tracking Centene stock to an alternative investment option, at a reference price of $59.60 per share. The filing states this did not involve any open market sale of securities.
Following the update, Carson reports ownership of 122,882 shares of common stock directly and 825 shares indirectly through his spouse. His holdings include 113,747 previously granted restricted stock units and performance stock units that remain subject to vesting. The phantom stock will be settled in cash or other non‑Centene securities upon his termination or another date he elects.
Centene Group President Michael A. Carson increased his deferred compensation exposure by acquiring 47.935 shares of phantom stock at $57.7700 per unit. Each phantom share represents the right to receive the fair market value of one Centene common share.
The phantom stock was obtained through regularly scheduled payroll contributions to the company’s deferred compensation plan and has no formal expiration date. After this award, Carson holds 604.004 phantom stock units, 122,882 shares of common stock held directly (including 113,747 restricted and performance stock units subject to vesting), and 825 common shares held indirectly by his spouse.
TANJI KENNETH reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Kenneth Tanji reported a stock award of 3,992 shares of common stock. The shares were granted at no cash cost to him as a compensation-related award and increase his direct holdings to 11,909 shares after the transaction.
According to the award terms, the 3,992 shares are in the form of restricted stock units that will vest in full on the earlier of May 12, 2027, or the date of Centene’s next annual meeting of stockholders.
Samuels Theodore R. II reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Theodore R. Samuels II received an equity grant of 3,992 shares of restricted stock units of Centene common stock. These units will vest in full on the earlier of May 12, 2027, or the date of Centene’s next annual meeting of stockholders. Following this grant, he holds 24,747.979 shares directly and 32,000 shares indirectly through a revocable family trust where he serves as co-trustee.
FORD MONTE E reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Monte E. Ford received a grant of 3,992 shares of common stock in the form of restricted stock units on May 12, 2026 at no cost. These units will vest in full on the earlier of May 12, 2027 or Centene’s next annual meeting of stockholders. Following this compensation award, Ford holds 14,826.771 shares directly, reflecting a routine equity-based director grant rather than an open-market purchase.
EPPINGER FREDERICK H reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp reported that director Frederick H. Eppinger received an equity grant of 6,654 shares of Common Stock in the form of restricted stock units, recorded at a price of $0.00 per share as this is a compensation award rather than a market purchase.
The award will vest in full on the earlier of May 12, 2027 or the date of Centene’s next annual meeting of stockholders. Following this grant, Eppinger directly holds a total of 368,704.658 shares of Centene common stock.
Dallas H James reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director James H. Dallas reported an equity award and updated share holdings. He received 3,992 shares of common stock in the form of restricted stock units at no cash cost. These units vest in full on the earlier of May 12, 2027, or the company’s next annual stockholder meeting.
Following this grant, Dallas directly holds 47,874.185 Centene common shares. He also indirectly holds 1,693 shares through a revocable family trust for which he serves as co-trustee. The filing reflects a compensation-related award rather than an open-market share purchase.
COUGHLIN CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Centene director Christopher J. Coughlin reported a new equity award and updated his holdings in Centene Corp. He received a grant of 3,992 shares of restricted stock units, which will vest in full on the earlier of May 12, 2027, or the date of Centene’s next annual stockholder meeting. Following this award, Coughlin directly holds 18,148.926 shares of Centene common stock. In addition, a grantor retained annuity trust for the benefit of Coughlin and his adult children holds 30,054 shares, which he reports as indirect ownership as sole trustee.
Burdick Kenneth A reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Kenneth A. Burdick received an equity award of 3,992 shares of common stock in the form of restricted stock units at no cash cost. These units vest in full on the earlier of May 12, 2027, or the date of Centene’s next annual meeting of stockholders. Following this grant, Burdick holds 277,085.924 shares of Centene common stock directly. An additional 86,498 shares are held indirectly by the Burdick Family LLC, for which he disclaims beneficial ownership except for his pecuniary interest.
BLUME JESSICA L. reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Jessica L. Blume received an equity award of 3,992 shares of common stock as restricted stock units. The grant price is shown as $0.00 per share, indicating a compensation award rather than an open-market purchase. These restricted stock units will vest in full on the earlier of May 12, 2027, or the date of Centene’s next annual meeting of stockholders.
Following this grant, Blume directly holds 32,357 shares of Centene common stock. She also has indirect ownership of 250 shares through a revocable family trust, where she serves as sole trustee. The filing does not report any open-market buys or sells, only this stock-based compensation grant and the trust holding.
Centene Corporation’s Chief People Officer Tanya M. McNally had 964 shares of common stock withheld on April 15, 2026 to cover tax obligations when previously granted restricted stock units vested at a price of $37.26 per share. After this tax-withholding disposition, she holds 127,258 shares directly, including 112,054 restricted and performance stock units that remain subject to vesting requirements.
Centene Corp director Kenneth Tanji reported receiving a grant of 1,179 shares of Common Stock as a compensation-related award. The shares were acquired at no purchase price, increasing his direct holdings to 7,917 shares. Ownership includes 3,579 restricted stock units that are subject to vesting requirements.
Samuels Theodore R. II reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Theodore R. Samuels II received a grant of 943 shares of Common Stock as a stock award. The award was recorded at a price of $0.00 per share and increased his directly held stake to 20,755.979 shares.
He also has indirect ownership of 32,000 shares through a revocable family trust where he serves as co-trustee. Ownership further includes 3,579 shares of restricted stock units that are subject to vesting requirements.
EPPINGER FREDERICK H reported acquisition or exercise transactions in this Form 4 filing.
Centene Corporation director Frederick H. Eppinger reported receiving a grant of 1,690 shares of common stock, recorded at $0.00 per share as a compensation-related award, not an open-market purchase. Following this grant, he directly holds 362,050.658 common shares.
A footnote states that this ownership figure also includes 5,965 shares of restricted stock units that are subject to vesting requirements, meaning those shares will be delivered only if the vesting conditions are met.
COUGHLIN CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Christopher J. Coughlin received an equity award of 1,140 shares of common stock on March 31, 2026. The shares were granted at no cash cost as a stock-based compensation award, increasing his directly held common stock to 14,156.926 shares.
He also has indirect ownership of 30,054 shares held by a grantor retained annuity trust for the benefit of Mr. Coughlin and his adult children, where he serves as sole trustee. His direct ownership includes 3,579 restricted stock units that remain subject to vesting requirements.
Centene Corp Chief Operating Officer handles tax withholding on vested stock units. Susan Raye Smith reported a disposition of 2,918 shares of Centene common stock at $34.45 per share, described as shares withheld to cover taxes when previously granted restricted stock units vested. This was not an open-market sale. After the withholding, she directly holds 212,720 shares, including 182,815 shares of restricted stock units and performance stock units that remain subject to vesting conditions.
Centene Corp Chief People Officer Tanya M. McNally had 2,785 shares of common stock withheld at $34.45 per share to cover taxes due on the vesting of previously granted restricted stock units. This was an automatic tax-withholding disposition, not an open-market sale.
After this transaction, she directly owns 128,222 shares of Centene common stock. Footnote disclosure states that this ownership figure includes 114,503 shares represented by previously granted restricted stock units and performance stock units, reported at target performance levels and still subject to vesting requirements.
Centene Corp Chief Executive Officer Sarah London reported a tax-related share disposition, not an open-market trade. On this Form 4, 36,061 shares of common stock were withheld at $34.45 per share to cover taxes when previously reported restricted stock units vested, according to a footnote.
After this withholding, London directly owns 1,188,831 shares of Centene common stock. This ownership includes 889,753 shares tied to previously granted restricted stock units and performance stock units, reported at target performance levels and still subject to vesting requirements.
The filing also shows a performance stock option covering 13,449 underlying shares of common stock with an exercise price of $81.85 per share, expiring on December 15, 2031. A footnote states this option, granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if Centene’s closing stock price equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
Centene Corporation’s Secretary & General Counsel Christopher Koster reported a tax-related share disposition. On March 15, 2026, 9,087 shares of common stock were withheld at $34.45 per share to cover taxes upon vesting of previously granted restricted stock units.
After this withholding, Koster directly holds 352,835.617 shares of Centene common stock, plus 100 shares indirectly through his spouse. His ownership also includes 229,874 restricted and performance stock units that remain subject to vesting conditions.
Koster’s remaining equity incentives include a performance stock option for 15,690 shares at an exercise price of $81.85 per share that may become exercisable if Centene’s stock trades at $100 or more for 20 consecutive days, as well as 3,015.544 phantom stock units payable in cash or other non-company securities at or after his termination or another elected date.
Centene Corp’s Corporate Controller and Chief Accounting Officer, Katie Casso, reported a routine tax-withholding transaction related to equity compensation. On March 15, 2026, 3,359 shares of common stock were withheld at $34.45 per share to cover taxes when previously granted restricted stock units vested. This was not an open-market sale. After the withholding, she directly owns 109,776 shares of common stock, and a footnote states her ownership also includes 71,740 unvested restricted and performance stock units reported at target performance.
Centene Corporation’s Chief Financial Officer Andrew Lynn reported a routine tax-withholding transaction. On March 15, 2026, 15,241 shares of Centene common stock were withheld at $34.45 per share to cover taxes upon vesting of previously reported restricted stock units. After this, he directly owns 747,989.48 shares, and this ownership includes 448,650 restricted stock units and performance stock units subject to future vesting. He also holds a performance stock option covering 13,449 underlying shares at an exercise price of $81.85 per share, expiring on December 15, 2031, which may become exercisable if Centene’s stock trades at or above $100 for 20 consecutive trading days on or after the third anniversary of the December 15, 2021 grant.
Centene Corp’s Corporate Controller and Chief Accounting Officer reported a new stock award and corrected prior holdings. On 01/26/2026, the officer acquired 26,036 shares of Centene common stock at $0 as equity compensation, bringing beneficial ownership to 113,135 shares held directly.
The award consists of 13,018 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 13,018 performance stock units reported at target. The performance stock units are scheduled to vest on March 15, 2029, with the actual number ranging from 0% to 200% of target based on Centene’s stock price performance for the final 20 trading days of 2025 compared to the final 60 trading days of 2028. The amendment also removes 9,236 shares from total holdings, reflecting performance stock units for the period ending December 31, 2025 that did not meet vesting criteria as determined on January 26, 2026.
Centene Corp’s Chief People Officer reported an equity award of 74,311 shares of common stock at $0 per share. After this grant, the officer beneficially owns 131,007 shares directly.
The new award includes 29,724 restricted stock units that vest in three annual installments beginning on March 15, 2027, plus 44,587 performance stock units reported at target. The performance units can vest from 0% to 200% of target on March 15, 2029, based on Centene’s stock price performance over specified trading periods in 2025 and 2028. This amended filing removes 2,073 previously counted performance stock units that did not meet vesting criteria, and notes that current ownership also includes 47,267 previously granted restricted and performance stock units subject to vesting.
Centene Corporation’s chief operating officer reported an amended equity award on Form 4/A. On January 26, 2026, the officer received 112,823 shares of common stock at $0, lifting direct beneficial ownership to 215,638 shares.
The award includes 45,129 restricted stock units that vest in three annual installments beginning March 15, 2027, plus 67,694 performance stock units at target. Those performance units can vest between 0% and 200% on March 15, 2029 based on Centene’s stock price performance over specified 2025 and 2028 trading periods. The amendment removes 9,651 unvested performance units that did not meet vesting criteria, and ownership also reflects 80,466 previously granted restricted and performance units still subject to vesting.
Centene Corporation’s secretary and general counsel, Christopher A. Koster, reported an award of 126,925 shares of common stock at a price of $0, increasing his directly held beneficial ownership to 361,922.617 shares.
The grant consists of 50,770 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 76,155 performance stock units reported at target. The performance units can vest at 0%–200% of target on March 15, 2029 based on the company’s stock price performance over specified trading-day windows in 2025 and 2028.
The amendment also updates Koster’s holdings to remove 26,939 shares tied to performance stock units for the period ending December 31, 2025 that did not meet vesting criteria, as determined on January 26, 2026. Current ownership includes 123,574 previously granted stock units that remain subject to vesting requirements.
Centene Corporation’s chief financial officer reported a new equity grant and corrected prior holdings. On 01/26/2026, the CFO acquired 173,573 shares of common stock at a price of $0, bringing beneficial ownership to 763,230.48 shares held directly.
The award includes 69,429 restricted stock units vesting in three annual installments beginning on March 15, 2027, plus 104,144 performance stock units at target that may vest on March 15, 2029, from 0% to 200% of target based on stock price performance tests. The amendment removes 67,985 performance stock units from total holdings because they did not meet vesting criteria for the performance period ending December 31, 2025, as determined by the Compensation and Talent Committee on January 26, 2026. Current ownership also includes 316,262 previously granted restricted and performance stock units subject to vesting.
Centene Corporation reported that its Chief Executive Officer received an equity award covering 520,720 shares of common stock at a price of $0. After this grant, the CEO beneficially owns 1,224,892 shares.
The award includes 138,859 restricted stock units vesting in three annual installments starting March 15, 2027, and 69,429 restricted stock units vesting in five annual installments starting the same date. It also includes 312,432 performance stock units at target, which can vest at 0% to 200% of this amount on March 15, 2029, based on stock price performance tests. The amendment removes 141,103 previously reported performance stock units that failed to meet vesting criteria, and ownership continues to reflect 450,895 previously granted restricted and performance stock units subject to vesting.
Centene Corporation’s Chief Operating Officer, Susan Raye Smith, received an equity award of 112,823 shares of common stock on January 26, 2026. The grant was reported at a price of $0 per share and increased her beneficial ownership to 225,289 shares.
The award consists of 45,129 restricted stock units that vest in three annual installments beginning March 15, 2027, and 67,694 performance stock units reported at target. The performance stock units are scheduled to vest on March 15, 2029, with the actual number earned ranging from 0% to 200% of the target amount, based on Centene’s stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028. Her total includes 90,117 previously granted restricted and performance stock units that remain subject to vesting requirements.
Centene Corporation granted Chief People Officer Tanya M. McNally 74,311 shares of common stock as equity compensation on January 26, 2026 at a price of $0 per share. Following this award, she beneficially owns 133,080 shares directly.
The new grant consists of 29,724 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 44,587 performance stock units reported at target. The performance stock units can vest from 0% to 200% of target on March 15, 2029 based on Centene’s stock price performance over specified trading-day periods in 2025 and 2028. Existing ownership also includes 49,340 previously granted restricted and performance stock units that remain subject to vesting.
Centene Corporation CEO Sarah London received a large equity grant reported on January 26, 2026. She was awarded 520,720 shares of Centene common stock at a grant price of $0, bringing her directly owned common stock to 1,365,995 shares.
The award includes 138,859 restricted stock units vesting in three annual installments beginning March 15, 2027, and 69,429 restricted stock units vesting in five annual installments beginning the same date. It also includes 312,432 performance stock units at target; the actual amount vesting on March 15, 2029 can range from 0% to 200% of that target based on Centene’s stock price performance over specified trading-day periods in 2025 and 2028.
Her ownership also reflects 591,998 previously granted restricted and performance stock units that remain subject to vesting. In addition, she directly holds a performance stock option for 13,449 shares at an exercise price of $81.85 per share, expiring December 15, 2031, which may become exercisable if Centene’s stock trades at or above $100 for 20 consecutive trading days after the original grant date.
Centene Corporation’s Secretary & General Counsel, Christopher Koster, reported an equity compensation grant and updated holdings. On January 26, 2026, he was awarded 126,925 shares of common stock at $0 per share, reflecting restricted stock units and performance stock units subject to future vesting.
Following this grant, Koster beneficially owns 388,861.617 shares of Centene common stock directly and 100 shares indirectly through his spouse. He also holds a performance stock option for 15,690 shares at an exercise price of $81.85 that may become exercisable if a share price hurdle is met, plus 3,015.544 phantom stock units settled in cash or other non‑company securities upon termination or an elected date.
Centene Corporation reported an equity grant to Corporate Controller & CAO Katie Casso. On January 26, 2026, she was awarded 26,036 shares of common stock at a price of $0, reflecting compensation rather than an open-market purchase.
The grant consists of 13,018 restricted stock units that vest in three annual installments beginning on March 15, 2027, and 13,018 performance stock units that may vest on March 15, 2029, from 0% to 200% of target based on Centene’s stock price performance between late 2025 and late 2028. After this award, Casso beneficially owns 122,371 shares, including 62,561 previously granted restricted and performance stock units that remain subject to vesting.
Centene Corporation’s Chief Financial Officer, Asher Andrew Lynn, reported an equity award of 173,573 shares of common stock on January 26, 2026, at a price of $0 per share. This grant brings his directly held beneficial ownership of Centene common stock to 831,215.48 shares.
The award includes 69,429 restricted stock units that vest in three annual installments beginning March 15, 2027, and 104,144 performance stock units reported at target, which may vest on March 15, 2029 from 0% to 200% of target based on stock price performance tests. He also holds 13,449 performance stock options with a $81.85 exercise price expiring December 15, 2031, which become exercisable only if Centene’s stock trades at or above $100 for 20 consecutive trading days after the December 15, 2021 grant date.
Centene Corp’s Chief People Officer, Tanya M. McNally, reported a routine tax-related share transaction. On 01/15/2026, 725 shares of Centene common stock were withheld at a price of $46.17 per share to cover taxes due on the vesting of a previously reported grant of restricted stock units. After this withholding, she beneficially owns 58,769 shares of Centene common stock, which includes 49,340 shares in the form of previously granted restricted stock units and performance stock units reported at target performance and still subject to vesting requirements.
Centene Corporation director reports a routine stock grant. On 12/31/2025, the reporting person acquired 790 shares of Centene common stock at a price of $0, indicating an award rather than an open-market purchase.
After this grant, the director beneficially owned 6,738 shares of Centene common stock in direct ownership. The filing also explains that this total includes 3,579 shares of restricted stock units that are subject to vesting requirements, meaning some shares will only be fully owned if those conditions are met.
Centene Corp director updates equity ownership in a routine insider filing. On 12/31/2025, the director acquired 608 shares of Centene common stock at a reported price of $0, likely reflecting a grant rather than an open-market purchase. Following this transaction, the director beneficially owns 19,812.979 shares directly, including 3,579 restricted stock units that are subject to vesting requirements, and 32,000 shares held indirectly through a revocable family trust where he serves as co‑trustee.
The filing also lists a stock option giving the right to buy 10,000 shares of Centene common stock at an exercise price of $80.57, exercisable from 02/07/2025 until 02/07/2032, with all 10,000 derivative securities currently reported as beneficially owned.
Centene Corp director Christopher A. Koster reported acquiring 608 shares of Centene common stock on 12/31/2025 at a price of $0 per share. Following this transaction, he beneficially owned 360,360.658 shares of Centene common stock in total. The filing notes that this ownership includes 5,965 shares of restricted stock units that are subject to vesting requirements. The securities are held in direct ownership form.
Centene Corporation director Robert K. Coughlin reported updated holdings of the company’s stock and options. On 12/31/2025, he acquired 729 shares of common stock at a stated price of $0, bringing his directly held common stock to 13,016.926 shares.
He also reports 30,054 shares held indirectly through a grantor retained annuity trust. His ownership includes 3,579 restricted stock units that are subject to vesting. In addition, he holds a stock option to buy 10,000 Centene common shares at an exercise price of $80.57, exercisable from 02/07/2025 until expiration on 02/07/2032.